Trial overview

The PREVAiLS Study is a clinical study that evaluates whether the study drug pridopidine, can help people living with ALS.

Open for participation

NeurALS (LTX-002-101)

LTX-002-101 investigates the safety and tolerability of intrathecally administrated LTX-002 in participants with ALS.

Open for participation

FUNCtion ALS trial

The FUNCtion ALS trial investigates the safety and tolerability of the drug TRCN-1023 in different doses.

Closed for participation

DAZALS

Phase 2

In this study, an investigational oral drug named dazucorilant (also called CORT113176) is being studied in people living with ALS.

Closed for participation

AP101-02 trial

Phase 2

In this study we investigate the safety, tolerability, pharmacodynamics markers and pharmacokinetics of AP-101 in patients with ALS.

Closed for participation

ATLAS

SOD1

This trial evaluates the efficacy and safety and of an investigational drug for pre-symptomatic carriers of the SOD1 gene.

Do you have questions about clinical trials?

Closed for participation

FUSION

FUS

This study investigates the safety & efficacy of the study drug ‘ION363’ for the treatment of ALS caused by mutations in the FUS gene.

Closed for participation

PRO-101 trial

In this research we investigate the safety of the new drug prosetin for the treatment of ALS.

Closed for participation

MAGNET lithium trial

IIT

UNC13A

The MAGNET lithium trial studies the efficacy of lithium carbonate in ALS patients positive for the homozygous UNC13A mutation.

Closed for participation

EPISOD1

SOD1

The EPISOD1 ph 1/2 study evaluates the gene therapy AMMT-162 in participants with SOD1-ALS.

Closed for participation

reALiSe

Phase 2

In the reALiSe study the safety and efficacy of the drug ARGX-119 for the treatment of ALS is investigated.